Home / Brands / Dr. Reddy's Laboratories
Dr. Reddy's Laboratories Recalls
165 recalls on record · August 8, 2012 to December 17, 2025 · Drugs
Recalls by year
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
June 14, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By:
Hazard: Failed Dissolution Specifications: out of specification results observed for low dissolution.
April 12, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachup
Hazard: Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
March 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Zenatane (isotretinoin) capsules, 10 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:
Hazard: Failed dissolution specifications - low dissolution results at S3 stage.
March 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:
Hazard: Failed dissolution specifications - low dissolution results at S3 stage.
March 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Zenatane (isotretinoin) capsules, 20 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:
Hazard: Failed dissolution specifications - low dissolution results at S3 stage.
March 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Zenatane (isotretinoin) capsules, 40 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:
Hazard: Failed dissolution specifications - low dissolution results at S3 stage.
February 15, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bach
Hazard: Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.
February 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Flucanozole Tablets, USP, 200 mg, a) 30 count (NDC 55111-146-30) and b) 100 count (NDC 55111-146-01) bottles, Rx Only, M
Hazard: Failed Dissolution Specifications; 18 month stability time point
February 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Flucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 Ind
Hazard: Failed Dissolution Specifications; 18 month stability time point
February 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Flucanozole Tablets, USP, 100 mg, a) 30 count (NDC 55111-144-30) and b) 100 count (NDC 55111-144-01) bottles, Rx Only, M
Hazard: Failed Dissolution Specifications; 18 month stability time point
February 8, 2017DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Flucanozole Tablets, USP, 50 mg, a) 30 count (NDC 55111-143-30) and b) 100 count (NDC 55111-143-01) bottles, Rx Only, Mf
Hazard: Failed Dissolution Specifications; 18 month stability time point
October 19, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls ZENATANE (isotretinoin capsules USP) 20 mg, 30 capsules per prescription pack, Rx Only, Manufactured by: Cipla Limited,
Hazard: Failed Dissolution Specifications
July 13, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Sirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Visakhapatnam - 5
Hazard: Failed impurities/degradation: out of specification result for impurity secorapamycin.
July 6, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls CVS pharmacy Original Strength Acid Controller tablets, 10 mg, 30-count bottle, OTC, Distributed by: CVS Pharmacy, Inc.
Hazard: Failed impurities/degradation specification: An out of specification results has been determined for an individual related substance during stability testing at the 18th month interval for the Famotidine 10 mg Tablet, USP.
May 18, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ondansetron Tablets USP, 4 mg, 30 count bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories, Bachupally, India -
Hazard: Failed Impurities/Degradation Specifications; 12 month stability time point
April 6, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL), 100 mL Single Use Bottle, Rx Only, Mfd. By: Gland Pharma Limited D.
Hazard: Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial
February 24, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Paricalcitol Capsules, 4 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, Ind
Hazard: Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
February 24, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Paricalcitol Capsules, 2 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, Ind
Hazard: Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
February 24, 2016DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Paricalcitol Capsules, 1 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, Ind
Hazard: Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.
September 2, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium Tablets, 10 mg/80 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy'
Hazard: Subpotent Drug: Subpotent atorvastatin.
September 2, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium Tablets,10 mg/40 mg, Packaged in a) 30 Count Bottles (NDC: 43598-315-30) an
Hazard: Subpotent Drug: Subpotent atorvastatin.
September 2, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium Tablets, 10 mg/20 mg, Packaged in a) 30 Count Bottles (NDC: 43598-318-30) a
Hazard: Subpotent Drug: Subpotent atorvastatin.
September 2, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium Tablets, 5 mg/20 mg, Packaged in a) 30 Count Bottles (NDC: 43598-319-30) an
Hazard: Subpotent Drug: Subpotent atorvastatin.
September 2, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium Tablets,2.5 mg/40 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy'
Hazard: Subpotent Drug: Subpotent atorvastatin.
September 2, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium Tablets, 2.5 mg/20 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy
Hazard: Subpotent Drug: Subpotent atorvastatin.
September 2, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium Tablets, 2.5 mg/10 mg, 30 Count Bottles, Rx Only. Manufactured by Dr. Reddy
Hazard: Subpotent Drug: Subpotent atorvastatin.
August 19, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By Dr. Reddy's Laboratories Limited, Bachupal
Hazard: Failed Dissolution Specifications
June 24, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium tablets, 5mg/40mg packaged in a)30-count bottle (NDC 43598-316-30), b) 90-c
Hazard: Subpotent drug
June 24, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium tablets, 10mg/40mg, 90-count bottle, Rx Only Manufactured by Dr. Reddy's La
Hazard: Subpotent drug
June 24, 2015DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Amlodipine besylate and Atorvastatin calcium tablets, 10mg/10mg, packaged in a)30-count bottle (NDC 43598-321-30), b) 90
Hazard: Subpotent drug